ASPI vs LIN

For growth investors, ASP Isotopes Inc.

Common Stock (ASPI) is the stronger pick with 857. 0% revenue growth year-over-year, versus 3. 0% for Linde plc (LIN). Linde plc (LIN) offers the better valuation at 34. 4x trailing P/E (28. 1x forward), making it the more compelling value choice. Analysts rate ASP Isotopes Inc. Common Stock (ASPI) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, ASP Isotopes Inc.

Common Stock (ASPI) delivered a total return of +107. 5%, compared to +78. 1% for Linde plc (LIN). Over 10 years, the gap is even starker: LIN returned +376. 9% versus ASPI's +107. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Linde plc (LIN) is the lower-risk stock at 0.

24β versus ASP Isotopes Inc. Common Stock's 2. 70β — meaning ASPI is approximately 1024% more volatile than LIN relative to the S&P 500. On balance sheet safety, Linde plc (LIN) carries a lower debt/equity ratio of 68% versus 74% for ASP Isotopes Inc. Common Stock — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), ASP Isotopes Inc.

Common Stock (ASPI) is pulling ahead at 857. 0% versus 3. 0% for Linde plc (LIN). On earnings-per-share growth, the picture is similar: Linde plc grew EPS 7. 1% year-over-year, compared to -28. 6% for ASP Isotopes Inc. Common Stock. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Linde plc (LIN) is the more profitable company, earning 20.

3% net margin versus -780. 2% for ASP Isotopes Inc. Common Stock — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LIN leads at 26. 3% versus -635. 9% for ASPI. At the gross margin level — before operating expenses — LIN leads at 43. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for ASPI: 134.

7% to $13. 00.

All stocks in this comparison pay dividends.

ASP Isotopes Inc. Common Stock (ASPI) offers the highest yield at 100. 0%, versus 1. 2% for Linde plc (LIN).

For long-horizon retirement investors, Linde plc (LIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

24), 1. 2% yield, +376. 9% 10Y return). ASP Isotopes Inc. Common Stock (ASPI) carries a higher beta of 2. 70 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LIN: +376. 9%, ASPI: +107. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: ASPI is a small-cap high-growth stock; LIN is a large-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.